Compare PCAR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCAR | BSX |
|---|---|---|
| Founded | 1905 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.6B | 68.0B |
| IPO Year | 2011 | 2010 |
| Metric | PCAR | BSX |
|---|---|---|
| Price | $102.08 | $41.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 31 |
| Target Price | ★ $128.44 | $51.53 |
| AVG Volume (30 Days) | 3.3M | ★ 16.4M |
| Earning Date | 10-27-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 4.18 | 1.51 |
| Revenue | ★ $28,444,800,000.00 | $9,076,000,000.00 |
| Revenue This Year | $0.01 | $4.44 |
| Revenue Next Year | $9.18 | $0.30 |
| P/E Ratio | ★ $24.47 | $28.30 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $93.86 | $39.57 |
| 52 Week High | $139.24 | $105.65 |
| Indicator | PCAR | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 25.18 | 40.29 |
| Support Level | N/A | N/A |
| Resistance Level | $130.37 | $46.09 |
| Average True Range (ATR) | 2.65 | 1.41 |
| MACD | -0.31 | -0.17 |
| Stochastic Oscillator | 15.47 | 36.57 |
Paccar is a leading manufacturer of medium- and heavy-duty trucks under the premium nameplates Kenworth and Peterbilt, which are primarily sold in the Americas and Australia, and DAF, which primarily services Europe and South America. The trucks segment (74% sales) goes to market through a network of 2,200 independent dealers. Paccar maintains an internal finance subsidiary that provides retail and wholesale financing for customers and dealers (6% sales). In recent years, Paccar has aggressively expanded its parts business (20% of sales), including engines, axles, and transmissions for its own truck brands as well as independent producers. The company commands 30% of the Class 8 market share in North America and 15% of the heavy-duty market share in Europe.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.